D. Manno

发表

The knowledge system underpinning healthcare is not fit for purpose and must change

Phil Edwards, Katharine Ker, Ian Roberts, 2015, BMJ : British Medical Journal.

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Raghavendra C Kamath, Jennifer L. Small, J. Cuzick, 2020, Lancet.

Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial

I. Roberts, D. Prieto-Merino, D. Manno, 2014, Critical Care.

Hepatitis B virus and HIV coinfection in low-income countries: unmet needs.

G. Carosi, M. Puoti, P. Nasta, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country

D. Watson-Jones, B. Greenwood, D. Ishola, 2018, Clinical trials.

Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin

S. Babudieri, M. Puoti, D. Manno, 2008, Infection.

Variability in the Incidence of Classic Kaposi's Sarcoma in the Veneto Region, Northern Italy

M. Zorzi, P. Zambon, S. Guzzinati, 2003, Tumori.

Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP)

G. Cuomo, C. Mussini, M. Puoti, 2018, Infectious diseases.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

S. Lees, D. Watson-Jones, B. Lowe, 2021, The Lancet. Infectious diseases.

HCV infection: pathogenesis, clinical manifestations and therapy.

I. Olivieri, D. Vergani, G. Mieli-Vergani, 2008, Clinical and experimental rheumatology.

Extending evidence for the use of tranexamic acid from traumatic haemorrhage to other patients with major bleeding: do we need more than one haemorrhage protocol? The case of gastrointestinal bleeding

P. Edwards, I. Roberts, S. Stanworth, 2015, Transfusion medicine.

How effective is tranexamic acid for acute gastrointestinal bleeding?

I. Roberts, K. Ker, D. Manno, 2014, BMJ : British Medical Journal.

Kaposi's sarcoma, human herpesvirus 8 infection and the potential role of promoter‐arthropod bites in northern Sweden

M. Coluzzi, V. Ascoli, D. Manno, 2006, Journal of medical virology.

Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in Zambia

M. Monze, S. Filteau, N. Larke, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The burden of HIV and hepatitis C virus coinfection

G. Carosi, M. Puoti, P. Nasta, 2007, Current opinion in HIV and AIDS.

HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial

P. Edwards, I. Roberts, K. Ker, 2014, Trials.

Treating hepatitis C virus in HIV patients: are side effects a real obstacle?

G. Carosi, M. Puoti, P. Nasta, 2007, AIDS reviews.

Nutrition and HIV/AIDS

S. Filteau, D. Manno, 2013 .

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone

D. Watson-Jones, D. Ishola, E. Smout, 2022, Emerging infectious diseases.

Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children

D. Watson-Jones, Pauline Akoo, D. Ishola, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania

S. Kapiga, D. Watson-Jones, P. Kaleebu, 2019, The Journal of infectious diseases.

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

S. Lees, D. Watson-Jones, B. Lowe, 2021, The Lancet. Infectious diseases.

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.

D. Watson-Jones, C. McLean, G. Deen, 2022, The Lancet. Infectious diseases.

Geographic variation in human herpesvirus 8 seroprevalence and possible association with exposure to bites from blood-sucking arthropods.

M. Coluzzi, V. Ascoli, D. Manno, 2006, The Journal of infectious diseases.

Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites.

T. Schulz, L. Chieco‐Bianchi, M. Coluzzi, 2004, The Journal of infectious diseases.

Reduced seroprevalence of Kaposi's sarcoma‐associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy

L. Chieco‐Bianchi, M. Coluzzi, V. Ascoli, 2003, Medical and veterinary entomology.

Developing a vaccine against Marburg virus disease

D. Manno, 2023, The Lancet.

Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial

D. Heimburger, S. Filteau, A. Rehman, 2015, BMC Medicine.

HHV-8 transmission via saliva to soothe blood-sucking arthropod bites

T. Schulz, L. Chieco‐Bianchi, M. Coluzzi, 2004, British Journal of Cancer.

The bloodsucking arthropod bite as possible cofactor in the transmission of human herpesvirus-8 infection and in the expression of Kaposi's sarcoma disease.

P. Zambon, S. Guzzinati, S. Tognazzo, 2002, Parassitologia.

Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure.

U. Gompels, M. Monze, S. Filteau, 2013, Vaccine.

Risk Factors and Clinical Characteristics Associated with Hospitalization for Community-Acquired Bacterial Pneumonia in HIV-Positive Patients According to the Presence of Liver Cirrhosis

G. Cristini, G. Carosi, M. Puoti, 2009, Infection.

Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.

M. Antonelli, G. Fadda, M. Sanguinetti, 2008, The Journal of antimicrobial chemotherapy.

Rich micronutrient fortification of locally produced infant food does not improve mental and motor development of Zambian infants: a randomised controlled trial

S. Jaffar, B. D. De Stavola, S. Filteau, 2011, British Journal of Nutrition.

The effects of micronutrient-fortified complementary/replacement food on intestinal permeability and systemic markers of inflammation among maternally HIV-exposed and unexposed Zambian infants.

S. Filteau, N. Larke, D. Manno, 2012, The British journal of nutrition.

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

D. Watson-Jones, C. Drakeley, S. Soremekun, 2023, Vaccines.

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study

S. Sirima, J. Lelièvre, H. Kibuuka, 2024, Vaccines.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.

D. Watson-Jones, E. D’Ortenzio, D. Ishola, 2023, The Lancet. Global health.

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.

D. Watson-Jones, P. Kaleebu, O. Anzala, 2023, Vaccine.

How effective is tranexamic acid for acute gastrointestinal bleeding?

I. Roberts, K. Ker, D. Manno, 2014, BMJ : British Medical Journal.